KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $883000.0.

  • Staar Surgical's Capital Expenditures fell 8582.89% to $883000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year decrease of 5245.94%. This contributed to the annual value of $23.4 million for FY2024, which is 2862.33% up from last year.
  • Per Staar Surgical's latest filing, its Capital Expenditures stood at $883000.0 for Q3 2025, which was down 8582.89% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Staar Surgical's Capital Expenditures peaked at $9.2 million during Q3 2023, and registered a low of $883000.0 during Q3 2025.
  • For the 5-year period, Staar Surgical's Capital Expenditures averaged around $3.9 million, with its median value being $3.4 million (2021).
  • Per our database at Business Quant, Staar Surgical's Capital Expenditures skyrocketed by 27967.61% in 2021 and then tumbled by 8582.89% in 2025.
  • Staar Surgical's Capital Expenditures (Quarter) stood at $4.7 million in 2021, then decreased by 14.16% to $4.0 million in 2022, then decreased by 23.28% to $3.1 million in 2023, then skyrocketed by 85.4% to $5.7 million in 2024, then crashed by 84.58% to $883000.0 in 2025.
  • Its last three reported values are $883000.0 in Q3 2025, $1.8 million for Q2 2025, and $1.5 million during Q1 2025.